| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 4.79e-10 | 5 | 64 | 4 | GO:0052871 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 3.33e-09 | 7 | 64 | 4 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 3.33e-09 | 7 | 64 | 4 | GO:0018685 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 1.99e-08 | 10 | 64 | 4 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 1.99e-08 | 10 | 64 | 4 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 1.99e-08 | 10 | 64 | 4 | GO:0102033 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 6.71e-08 | 13 | 64 | 4 | GO:0016713 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 9.72e-07 | 24 | 64 | 4 | GO:0008392 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 1.59e-06 | 27 | 64 | 4 | GO:0008391 | |
| GeneOntologyMolecularFunction | aromatase activity | 4.66e-06 | 35 | 64 | 4 | GO:0070330 | |
| GeneOntologyMolecularFunction | cAMP response element binding protein binding | 6.77e-06 | 12 | 64 | 3 | GO:0008140 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 8.04e-06 | 40 | 64 | 4 | GO:0016709 | |
| GeneOntologyMolecularFunction | 20-hydroxy-leukotriene B4 omega oxidase activity | 1.01e-05 | 2 | 64 | 2 | GO:0097258 | |
| GeneOntologyMolecularFunction | 20-aldehyde-leukotriene B4 20-monooxygenase activity | 1.01e-05 | 2 | 64 | 2 | GO:0097259 | |
| GeneOntologyMolecularFunction | arachidonate binding | 1.39e-05 | 15 | 64 | 3 | GO:0050544 | |
| GeneOntologyMolecularFunction | icosanoid binding | 1.71e-05 | 16 | 64 | 3 | GO:0050542 | |
| GeneOntologyMolecularFunction | icosatetraenoic acid binding | 1.71e-05 | 16 | 64 | 3 | GO:0050543 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 1.82e-05 | 49 | 64 | 4 | GO:0016712 | |
| GeneOntologyMolecularFunction | long-chain fatty acid binding | 9.72e-05 | 28 | 64 | 3 | GO:0036041 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 5.08e-04 | 115 | 64 | 4 | GO:0004497 | |
| GeneOntologyMolecularFunction | calmodulin binding | 8.52e-04 | 230 | 64 | 5 | GO:0005516 | |
| GeneOntologyMolecularFunction | leucine zipper domain binding | 8.98e-04 | 14 | 64 | 2 | GO:0043522 | |
| GeneOntologyMolecularFunction | fatty acid binding | 1.41e-03 | 69 | 64 | 3 | GO:0005504 | |
| GeneOntologyMolecularFunction | heme binding | 1.51e-03 | 154 | 64 | 4 | GO:0020037 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 1.90e-03 | 164 | 64 | 4 | GO:0046906 | |
| GeneOntologyMolecularFunction | iron ion binding | 1.99e-03 | 166 | 64 | 4 | GO:0005506 | |
| GeneOntologyMolecularFunction | LRR domain binding | 2.24e-03 | 22 | 64 | 2 | GO:0030275 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 3.48e-03 | 194 | 64 | 4 | GO:0016705 | |
| GeneOntologyMolecularFunction | lipid binding | EPHX1 ICA1 PDIA2 ZFYVE26 CYP4F2 CYP4F12 DENND1C CYP4F11 SOAT2 | 4.08e-03 | 988 | 64 | 9 | GO:0008289 |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 4.42e-03 | 103 | 64 | 3 | GO:0008276 | |
| GeneOntologyMolecularFunction | adenylyltransferase activity | 4.43e-03 | 31 | 64 | 2 | GO:0070566 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 4.92e-03 | 107 | 64 | 3 | GO:0033293 | |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 1.18e-09 | 6 | 63 | 4 | GO:0036101 | |
| GeneOntologyBiologicalProcess | leukotriene B4 metabolic process | 2.75e-09 | 7 | 63 | 4 | GO:0036102 | |
| GeneOntologyBiologicalProcess | leukotriene catabolic process | 5.48e-09 | 8 | 63 | 4 | GO:0036100 | |
| GeneOntologyBiologicalProcess | icosanoid catabolic process | 2.57e-08 | 11 | 63 | 4 | GO:1901523 | |
| GeneOntologyBiologicalProcess | menaquinone catabolic process | 2.72e-08 | 3 | 63 | 3 | GO:0042361 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid catabolic process | 3.84e-08 | 12 | 63 | 4 | GO:0042758 | |
| GeneOntologyBiologicalProcess | menaquinone metabolic process | 1.08e-07 | 4 | 63 | 3 | GO:0009233 | |
| GeneOntologyBiologicalProcess | phylloquinone metabolic process | 1.08e-07 | 4 | 63 | 3 | GO:0042374 | |
| GeneOntologyBiologicalProcess | phylloquinone catabolic process | 1.08e-07 | 4 | 63 | 3 | GO:0042376 | |
| GeneOntologyBiologicalProcess | vitamin K catabolic process | 1.08e-07 | 4 | 63 | 3 | GO:0042377 | |
| GeneOntologyBiologicalProcess | prostaglandin catabolic process | 5.40e-07 | 6 | 63 | 3 | GO:1905344 | |
| GeneOntologyBiologicalProcess | prostanoid catabolic process | 5.40e-07 | 6 | 63 | 3 | GO:0062232 | |
| GeneOntologyBiologicalProcess | fatty acid derivative catabolic process | 5.55e-07 | 22 | 63 | 4 | GO:1901569 | |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 2.03e-06 | 68 | 63 | 5 | GO:0019369 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 2.89e-06 | 73 | 63 | 5 | GO:1901616 | |
| GeneOntologyBiologicalProcess | vitamin K metabolic process | 4.40e-06 | 11 | 63 | 3 | GO:0042373 | |
| GeneOntologyBiologicalProcess | fat-soluble vitamin catabolic process | 5.86e-06 | 12 | 63 | 3 | GO:0042363 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 7.35e-06 | 41 | 63 | 4 | GO:0006691 | |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 9.65e-06 | 14 | 63 | 3 | GO:0097267 | |
| GeneOntologyBiologicalProcess | vitamin catabolic process | 2.14e-05 | 18 | 63 | 3 | GO:0009111 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | EPHX1 TKFC INPP5B SREBF2 CYP4F2 CYP4F3 CYP4F12 CYP4F11 LEPR SOAT2 | 2.27e-05 | 641 | 63 | 10 | GO:1901615 |
| GeneOntologyBiologicalProcess | ketone catabolic process | 3.47e-05 | 21 | 63 | 3 | GO:0042182 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid metabolic process | 3.85e-05 | 124 | 63 | 5 | GO:0001676 | |
| GeneOntologyBiologicalProcess | unsaturated fatty acid metabolic process | 4.48e-05 | 128 | 63 | 5 | GO:0033559 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 7.35e-05 | 142 | 63 | 5 | GO:0006690 | |
| GeneOntologyBiologicalProcess | fatty acid derivative metabolic process | 1.16e-04 | 82 | 63 | 4 | GO:1901568 | |
| GeneOntologyBiologicalProcess | vitamin E metabolic process | 1.37e-04 | 6 | 63 | 2 | GO:0042360 | |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 2.23e-04 | 180 | 63 | 5 | GO:0120254 | |
| GeneOntologyBiologicalProcess | cellular catabolic process | CHMP7 DAPK2 UBR4 SREBF2 DAPK1 DAPK3 ZFYVE26 CYP4F2 CYP4F3 CYP4F12 CYP4F11 LEPR | 3.57e-04 | 1253 | 63 | 12 | GO:0044248 |
| GeneOntologyBiologicalProcess | cellular response to topologically incorrect protein | 4.38e-04 | 116 | 63 | 4 | GO:0035967 | |
| GeneOntologyBiologicalProcess | fatty acid catabolic process | 4.38e-04 | 116 | 63 | 4 | GO:0009062 | |
| GeneOntologyBiologicalProcess | fat-soluble vitamin metabolic process | 5.09e-04 | 51 | 63 | 3 | GO:0006775 | |
| GeneOntologyBiologicalProcess | process utilizing autophagic mechanism | 7.83e-04 | 650 | 63 | 8 | GO:0061919 | |
| GeneOntologyBiologicalProcess | autophagy | 7.83e-04 | 650 | 63 | 8 | GO:0006914 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 9.12e-04 | 141 | 63 | 4 | GO:0006805 | |
| MousePheno | abnormal pancreatic beta cell mass | 1.80e-05 | 47 | 47 | 4 | MP:0009112 | |
| Domain | DAPK1 | 3.66e-08 | 3 | 63 | 3 | IPR020676 | |
| Domain | Cyt_P450_E_grp-I | 1.58e-05 | 45 | 63 | 4 | IPR002401 | |
| Domain | Cyt_P450_CS | 3.04e-05 | 53 | 63 | 4 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 4.06e-05 | 57 | 63 | 4 | PS00086 | |
| Domain | - | 4.35e-05 | 58 | 63 | 4 | 1.10.630.10 | |
| Domain | p450 | 4.35e-05 | 58 | 63 | 4 | PF00067 | |
| Domain | Cyt_P450 | 4.97e-05 | 60 | 63 | 4 | IPR001128 | |
| Domain | Hempt_rcpt_S_F1_CS | 3.97e-04 | 9 | 63 | 2 | IPR003531 | |
| Domain | DUF1605 | 1.47e-03 | 17 | 63 | 2 | IPR011709 | |
| Domain | OB_NTP_bind | 1.47e-03 | 17 | 63 | 2 | PF07717 | |
| Domain | HA2 | 1.65e-03 | 18 | 63 | 2 | SM00847 | |
| Domain | HA2 | 1.65e-03 | 18 | 63 | 2 | PF04408 | |
| Domain | Helicase-assoc_dom | 1.65e-03 | 18 | 63 | 2 | IPR007502 | |
| Domain | FN3 | 3.52e-03 | 185 | 63 | 4 | SM00060 | |
| Domain | - | 4.06e-03 | 95 | 63 | 3 | 2.60.120.200 | |
| Domain | FN3 | 4.56e-03 | 199 | 63 | 4 | PS50853 | |
| Domain | FN3_dom | 5.42e-03 | 209 | 63 | 4 | IPR003961 | |
| Domain | Helicase_C | 5.81e-03 | 108 | 63 | 3 | IPR001650 | |
| Domain | bZIP_1 | 5.86e-03 | 34 | 63 | 2 | PF00170 | |
| Domain | Znf_FYVE-rel | 5.86e-03 | 34 | 63 | 2 | IPR017455 | |
| Domain | HELICASE_CTER | 5.96e-03 | 109 | 63 | 3 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 5.96e-03 | 109 | 63 | 3 | PS51192 | |
| Domain | DEXDc | 5.96e-03 | 109 | 63 | 3 | SM00487 | |
| Domain | Helicase_ATP-bd | 6.11e-03 | 110 | 63 | 3 | IPR014001 | |
| Domain | ConA-like_dom | 6.38e-03 | 219 | 63 | 4 | IPR013320 | |
| Domain | Znf_FYVE | 7.28e-03 | 38 | 63 | 2 | IPR000306 | |
| Domain | ZF_FYVE | 8.04e-03 | 40 | 63 | 2 | PS50178 | |
| Domain | Laminin_G_2 | 8.04e-03 | 40 | 63 | 2 | PF02210 | |
| Domain | LamG | 9.67e-03 | 44 | 63 | 2 | SM00282 | |
| Pathway | REACTOME_EICOSANOIDS | 8.62e-08 | 12 | 53 | 4 | M27129 | |
| Pathway | REACTOME_EICOSANOIDS | 8.62e-08 | 12 | 53 | 4 | MM14845 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 1.73e-07 | 14 | 53 | 4 | MM15842 | |
| Pathway | REACTOME_FATTY_ACIDS | 2.36e-07 | 15 | 53 | 4 | M27126 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 5.24e-07 | 18 | 53 | 4 | MM14843 | |
| Pathway | REACTOME_FATTY_ACIDS | 5.24e-07 | 18 | 53 | 4 | MM14841 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 2.12e-06 | 25 | 53 | 4 | MM14858 | |
| Pathway | REACTOME_CASPASE_ACTIVATION_VIA_DEPENDENCE_RECEPTORS_IN_THE_ABSENCE_OF_LIGAND | 5.91e-06 | 10 | 53 | 3 | M866 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 6.72e-06 | 33 | 53 | 4 | MM15918 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 6.72e-06 | 33 | 53 | 4 | MM15963 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 8.11e-06 | 11 | 53 | 3 | MM14863 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 1.08e-05 | 12 | 53 | 3 | M27128 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 4.30e-05 | 104 | 53 | 5 | M738 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 4.50e-05 | 105 | 53 | 5 | MM14842 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 6.36e-05 | 21 | 53 | 3 | M27137 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 7.93e-05 | 61 | 53 | 4 | MM14861 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 8.45e-05 | 62 | 53 | 4 | M39653 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 9.57e-05 | 64 | 53 | 4 | M5650 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.08e-04 | 66 | 53 | 4 | MM14839 | |
| Pathway | REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY | 1.23e-04 | 26 | 53 | 3 | M27434 | |
| Pathway | WP_BLADDER_CANCER | 4.49e-04 | 40 | 53 | 3 | M39523 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY | 4.91e-04 | 9 | 53 | 2 | M39819 | |
| Pathway | KEGG_BLADDER_CANCER | 5.19e-04 | 42 | 53 | 3 | M19096 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 6.05e-04 | 183 | 53 | 5 | M39588 | |
| Pathway | WP_TRYPTOPHAN_METABOLISM | 7.70e-04 | 48 | 53 | 3 | MM15902 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_CREB_MEDIATED_TRANSCRIPTION | 1.05e-03 | 13 | 53 | 2 | M47595 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_CREB_MEDIATED_TRANSCRIPTION | 1.05e-03 | 13 | 53 | 2 | M47674 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.35e-03 | 219 | 53 | 5 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.38e-03 | 220 | 53 | 5 | M10320 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.41e-03 | 59 | 53 | 3 | M27140 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DRD1_GNAS_AC_PKA_SIGNALING_PATHWAY | 1.61e-03 | 16 | 53 | 2 | M47551 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKACA_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 1.82e-03 | 17 | 53 | 2 | M47514 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKAR1A_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 2.04e-03 | 18 | 53 | 2 | M47516 | |
| Pathway | WP_CHOLESTASIS | 2.28e-03 | 19 | 53 | 2 | M45520 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PDE11A_PDE8B_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 2.52e-03 | 20 | 53 | 2 | M47517 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_RAS_ERK_SIGNALING_PATHWAY | 2.78e-03 | 21 | 53 | 2 | M47792 | |
| Pubmed | Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11. | 1.26e-11 | 4 | 67 | 4 | 18065749 | |
| Pubmed | 1.88e-10 | 6 | 67 | 4 | 9068972 | ||
| Pubmed | The death-associated protein kinases: structure, function, and beyond. | 6.83e-09 | 3 | 67 | 3 | 16756490 | |
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 22665481 | ||
| Pubmed | Expression and catalytic activity of mouse leukotriene B4 omega-hydroxylase, CYP4F14. | 2.73e-08 | 4 | 67 | 3 | 11185557 | |
| Pubmed | 6.81e-08 | 5 | 67 | 3 | 22969154 | ||
| Pubmed | Cytochrome P4504f, a potential therapeutic target limiting neuroinflammation. | 6.81e-08 | 5 | 67 | 3 | 21466787 | |
| Pubmed | 2.38e-07 | 7 | 67 | 3 | 22160543 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 24138531 | ||
| Pubmed | Expression of CYP4F2 in human liver and kidney: assessment using targeted peptide antibodies. | 3.66e-06 | 2 | 67 | 2 | 18662666 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 31116076 | ||
| Pubmed | Sodium butyrate-induced DAPK-mediated apoptosis in human gastric cancer cells. | 3.66e-06 | 2 | 67 | 2 | 22160140 | |
| Pubmed | Expression and physiological function of CYP4F subfamily in human eosinophils. | 3.66e-06 | 2 | 67 | 2 | 17980168 | |
| Pubmed | Cloning and expression of a novel form of leukotriene B4 omega-hydroxylase from human liver. | 3.66e-06 | 2 | 67 | 2 | 8026587 | |
| Pubmed | Attenuation of EPO-dependent erythroblast formation by death-associated protein kinase-2. | 3.66e-06 | 2 | 67 | 2 | 18535204 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 22215680 | ||
| Pubmed | ZIP kinase, a novel serine/threonine kinase which mediates apoptosis. | 3.66e-06 | 2 | 67 | 2 | 9488481 | |
| Pubmed | New modularity of DAP-kinases: alternative splicing of the DRP-1 gene produces a ZIPk-like isoform. | 3.66e-06 | 2 | 67 | 2 | 21408167 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 15364545 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 17142457 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 29317536 | ||
| Pubmed | 1.05e-05 | 70 | 67 | 4 | 15128046 | ||
| Pubmed | Human CYP4F3s are the main catalysts in the oxidation of fatty acid epoxides. | 1.10e-05 | 3 | 67 | 2 | 15145985 | |
| Pubmed | Diabetes and insulin in regulation of brain cholesterol metabolism. | 1.10e-05 | 3 | 67 | 2 | 21109190 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 38424194 | ||
| Pubmed | MicroRNA-214 suppresses gluconeogenesis by targeting activating transcriptional factor 4. | 1.10e-05 | 3 | 67 | 2 | 25657009 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 11980920 | ||
| Pubmed | Lithium response and genetic variation in the CREB family of genes. | 1.10e-05 | 3 | 67 | 2 | 18189280 | |
| Pubmed | 1.45e-05 | 76 | 67 | 4 | 22323595 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 10629061 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 21883387 | ||
| Pubmed | DAPK-ZIPK-L13a axis constitutes a negative-feedback module regulating inflammatory gene expression. | 3.64e-05 | 5 | 67 | 2 | 18995835 | |
| Pubmed | 3.64e-05 | 5 | 67 | 2 | 27188441 | ||
| Pubmed | ZIP kinase triggers apoptosis from nuclear PML oncogenic domains. | 3.64e-05 | 5 | 67 | 2 | 12917339 | |
| Pubmed | 3.64e-05 | 5 | 67 | 2 | 18577768 | ||
| Pubmed | 5.46e-05 | 6 | 67 | 2 | 37949368 | ||
| Pubmed | Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6. | 5.46e-05 | 6 | 67 | 2 | 23881913 | |
| Pubmed | 5.46e-05 | 6 | 67 | 2 | 30683685 | ||
| Pubmed | Unfolded Protein Response (UPR) is activated during normal lens development. | 7.63e-05 | 7 | 67 | 2 | 21044701 | |
| Pubmed | 7.63e-05 | 7 | 67 | 2 | 23071094 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 8.40e-05 | 736 | 67 | 8 | 29676528 | |
| Pubmed | PTEN identified as important risk factor of chronic obstructive pulmonary disease. | 8.53e-05 | 374 | 67 | 6 | 19625176 | |
| Pubmed | Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. | 8.55e-05 | 44 | 67 | 3 | 12745259 | |
| Pubmed | 9.44e-05 | 381 | 67 | 6 | 18676680 | ||
| Pubmed | Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China. | 9.58e-05 | 382 | 67 | 6 | 19170196 | |
| Pubmed | 9.78e-05 | 46 | 67 | 3 | 25209997 | ||
| Pubmed | 1.02e-04 | 8 | 67 | 2 | 9756919 | ||
| Pubmed | 1.02e-04 | 8 | 67 | 2 | 37871017 | ||
| Pubmed | 1.02e-04 | 8 | 67 | 2 | 37591863 | ||
| Pubmed | 1.02e-04 | 8 | 67 | 2 | 19794411 | ||
| Pubmed | 1.02e-04 | 8 | 67 | 2 | 14685163 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 1.02e-04 | 560 | 67 | 7 | 21653829 | |
| Pubmed | Human immunodeficiency virus type 1 Vpr links proteasomal degradation and checkpoint activation. | 1.30e-04 | 9 | 67 | 2 | 17855541 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 1.58e-04 | 807 | 67 | 8 | 30575818 | |
| Pubmed | 1.62e-04 | 604 | 67 | 7 | 38803224 | ||
| Pubmed | Genetic susceptibility to distinct bladder cancer subphenotypes. | 1.62e-04 | 421 | 67 | 6 | 19692168 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 1.71e-04 | 268 | 67 | 5 | 33024031 | |
| Pubmed | A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study. | 1.99e-04 | 11 | 67 | 2 | 17903305 | |
| Pubmed | 1.99e-04 | 11 | 67 | 2 | 15001356 | ||
| Pubmed | CRL4(WDR23)-Mediated SLBP Ubiquitylation Ensures Histone Supply during DNA Replication. | 1.99e-04 | 11 | 67 | 2 | 27203182 | |
| Pubmed | 2.27e-04 | 638 | 67 | 7 | 33239621 | ||
| Pubmed | HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1. | 2.38e-04 | 12 | 67 | 2 | 17360488 | |
| Pubmed | 2.61e-04 | 653 | 67 | 7 | 22586326 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 2.61e-04 | 1105 | 67 | 9 | 35748872 | |
| Pubmed | Alternative splice variants encoding unstable protein domains exist in the human brain. | 2.81e-04 | 13 | 67 | 2 | 15491607 | |
| Pubmed | Genetic determinants of warfarin dosing in the Han-Chinese population. | 2.81e-04 | 13 | 67 | 2 | 19958090 | |
| Pubmed | 3.82e-04 | 494 | 67 | 6 | 26831064 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 4.47e-04 | 942 | 67 | 8 | 31073040 | |
| Pubmed | 5.36e-04 | 193 | 67 | 4 | 19343046 | ||
| Pubmed | Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. | 5.82e-04 | 84 | 67 | 3 | 29563501 | |
| Pubmed | 6.36e-04 | 202 | 67 | 4 | 24639526 | ||
| Pubmed | 7.10e-04 | 208 | 67 | 4 | 22145905 | ||
| Pubmed | Heritability and genetic association analysis of cognition in the Diabetes Heart Study. | 7.50e-04 | 21 | 67 | 2 | 24684796 | |
| Pubmed | Noncoding RNA MaIL1 is an integral component of the TLR4-TRIF pathway. | 8.24e-04 | 22 | 67 | 2 | 32241891 | |
| Pubmed | 8.24e-04 | 22 | 67 | 2 | 28566324 | ||
| Pubmed | Comprehensive identification of human bZIP interactions with coiled-coil arrays. | 9.01e-04 | 23 | 67 | 2 | 12805554 | |
| Pubmed | 9.74e-04 | 591 | 67 | 6 | 15231748 | ||
| Pubmed | BTG4 is a meiotic cell cycle-coupled maternal-zygotic-transition licensing factor in oocytes. | 9.82e-04 | 24 | 67 | 2 | 27065194 | |
| Pubmed | 1.07e-03 | 25 | 67 | 2 | 30604742 | ||
| Pubmed | 1.07e-03 | 25 | 67 | 2 | 18992263 | ||
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 1.12e-03 | 235 | 67 | 4 | 30258100 | |
| Pubmed | CRL4AMBRA1 targets Elongin C for ubiquitination and degradation to modulate CRL5 signaling. | 1.21e-03 | 108 | 67 | 3 | 30166453 | |
| Pubmed | 1.24e-03 | 27 | 67 | 2 | 35147267 | ||
| Pubmed | 1.34e-03 | 28 | 67 | 2 | 20689807 | ||
| Pubmed | 1.34e-03 | 28 | 67 | 2 | 34163012 | ||
| Pubmed | 1.38e-03 | 249 | 67 | 4 | 30097533 | ||
| Pubmed | Large-scale cDNA transfection screening for genes related to cancer development and progression. | 1.41e-03 | 114 | 67 | 3 | 15498874 | |
| Pubmed | 1.46e-03 | 253 | 67 | 4 | 29911972 | ||
| Pubmed | The unfolded protein response: integrating stress signals through the stress sensor IRE1α. | 1.64e-03 | 31 | 67 | 2 | 22013210 | |
| Pubmed | 1.64e-03 | 1431 | 67 | 9 | 37142655 | ||
| Pubmed | 1.73e-03 | 1442 | 67 | 9 | 35575683 | ||
| Pubmed | 1.75e-03 | 32 | 67 | 2 | 36278411 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | 1.84e-03 | 1455 | 67 | 9 | 22863883 | |
| Pubmed | 1.86e-03 | 33 | 67 | 2 | 20102225 | ||
| Cytoband | 16q22.1 | 2.13e-05 | 110 | 67 | 4 | 16q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q22 | 1.54e-04 | 183 | 67 | 4 | chr16q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.63e-04 | 797 | 67 | 7 | chr19p13 | |
| Cytoband | 1p34 | 1.01e-03 | 32 | 67 | 2 | 1p34 | |
| Cytoband | 2p13.1 | 1.14e-03 | 34 | 67 | 2 | 2p13.1 | |
| Cytoband | 11q12.2 | 1.50e-03 | 39 | 67 | 2 | 11q12.2 | |
| Cytoband | 19p13.1 | 2.27e-03 | 48 | 67 | 2 | 19p13.1 | |
| Cytoband | 12q13.13 | 4.36e-03 | 67 | 67 | 2 | 12q13.13 | |
| GeneFamily | Ankyrin repeat domain containing|Death associated protein kinases | 1.34e-07 | 5 | 44 | 3 | 1021 | |
| GeneFamily | Cytochrome P450 family 4 | 1.70e-06 | 36 | 44 | 4 | 1003 | |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN | 6.59e-06 | 179 | 67 | 6 | M16932 | |
| Coexpression | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN | 1.76e-05 | 20 | 67 | 3 | MM1104 | |
| Coexpression | MIKKELSEN_MEF_LCP_WITH_H3K4ME3 | 1.95e-05 | 128 | 67 | 5 | M1966 | |
| Coexpression | ONDER_CDH1_TARGETS_1_UP | 2.89e-05 | 139 | 67 | 5 | M18757 | |
| Coexpression | WOO_LIVER_CANCER_RECURRENCE_DN | 4.82e-05 | 78 | 67 | 4 | M9911 | |
| Coexpression | MIKKELSEN_MCV6_LCP_WITH_H3K4ME3 | 6.01e-05 | 162 | 67 | 5 | M1960 | |
| Coexpression | MIKKELSEN_IPS_LCP_WITH_H3K4ME3 | 8.66e-05 | 175 | 67 | 5 | M1975 | |
| Coexpression | PARENT_MTOR_SIGNALING_UP | 9.70e-05 | 567 | 67 | 8 | M16909 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.69e-07 | 176 | 67 | 6 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.63e-07 | 193 | 67 | 6 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.87e-06 | 181 | 67 | 5 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.08e-06 | 182 | 67 | 5 | cc79e0cc21e2fdc4ef77f052818d27b9f707aec1 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.52e-06 | 184 | 67 | 5 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | facs-BAT-Fat-24m-Epithelial-Epcam+|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.98e-06 | 186 | 67 | 5 | b18d7398279a2d42414318aeb70514fd402f5a0a | |
| ToppCell | facs-Lung-EPCAM-24m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.98e-06 | 186 | 67 | 5 | 3c4994a1a7db06a61da8170e45e06aaef7896592 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.98e-06 | 186 | 67 | 5 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | facs-Lung-EPCAM-24m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.98e-06 | 186 | 67 | 5 | a583d6fc0f1e729f6e9fd18d7b49d6eab9ca32b9 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.98e-06 | 186 | 67 | 5 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.21e-06 | 187 | 67 | 5 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.07e-05 | 193 | 67 | 5 | af6ec2c2ba92aef3e41531c3c7215b3300437bd9 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.10e-05 | 194 | 67 | 5 | c5ef4ff73b4e51530656002e3a2fb7264cdf533d | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.10e-05 | 194 | 67 | 5 | b19e16a76d7342ff9a665d19c9151652916f17d4 | |
| ToppCell | PCW_05-06-Epithelial|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.10e-05 | 194 | 67 | 5 | 47a1369c22fcbfe00b08376eb610a61c355548db | |
| ToppCell | COVID_vent-Myeloid-Monocytic-Developing_Neutrophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.13e-05 | 195 | 67 | 5 | de23409b1b4146b8ae286850b829ec8dceed0117 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.19e-05 | 197 | 67 | 5 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.19e-05 | 197 | 67 | 5 | b8f62fcd6eb8f47b3cc41f616126f82c68a36e87 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.19e-05 | 197 | 67 | 5 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.21e-05 | 198 | 67 | 5 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|Control_saline / Treatment groups by lineage, cell group, cell type | 1.21e-05 | 198 | 67 | 5 | 030ef63e2fc5b3d601c1a48462d797aa19ee7ff5 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.21e-05 | 198 | 67 | 5 | 827aa9d919bf6d670961e5501e17d351676127e3 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.21e-05 | 198 | 67 | 5 | 9b161285df7a4e51618f3517cfc5b8221ba55786 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.21e-05 | 198 | 67 | 5 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | Control_saline-Epithelial_alveolar|Control_saline / Treatment groups by lineage, cell group, cell type | 1.21e-05 | 198 | 67 | 5 | 532b7ef4ad46fe35ad2c6bdf89f70a17f1a2e2e2 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.24e-05 | 199 | 67 | 5 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-05 | 199 | 67 | 5 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.24e-05 | 199 | 67 | 5 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.24e-05 | 199 | 67 | 5 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.24e-05 | 199 | 67 | 5 | 8c9ec5f05b79cf5ae1bf7aade603c171fb0226a9 | |
| ToppCell | Bronchial_Biopsy-Epithelial|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.24e-05 | 199 | 67 | 5 | ef5d8917c8d011184830a0b8197afc6266707b37 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.27e-05 | 200 | 67 | 5 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.27e-05 | 200 | 67 | 5 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.27e-05 | 200 | 67 | 5 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.27e-05 | 200 | 67 | 5 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.43e-05 | 130 | 67 | 4 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.77e-05 | 145 | 67 | 4 | b961b69befb15ff6f58635e0d4bda88ea732a346 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.22e-05 | 157 | 67 | 4 | 4766f7d545bf2d775390589460677519cb92f4d5 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.22e-05 | 157 | 67 | 4 | 1f21d78a467fe22c5ab75d0917b840c1ac93f32c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.22e-05 | 157 | 67 | 4 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-04 | 166 | 67 | 4 | 4d63c758d46e73311b864148c646bf081498dee7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-04 | 166 | 67 | 4 | 4160ccf9291072a6e2782f9ad141bc9a9747f3ad | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.14e-04 | 166 | 67 | 4 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-04 | 168 | 67 | 4 | e870d2e69316406f45112ed0bf324b24f902a99e | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-04 | 168 | 67 | 4 | 403aba73a0f9ffb32252288d075fad8a588ca440 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 169 | 67 | 4 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-04 | 175 | 67 | 4 | 442f261a3b2c4d2523f7d4089178f8c79cac2f0f | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-04 | 175 | 67 | 4 | 35fb7735dd3355476fe60404833cb60bd066bcf1 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 176 | 67 | 4 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 176 | 67 | 4 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.46e-04 | 177 | 67 | 4 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-04 | 178 | 67 | 4 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.49e-04 | 178 | 67 | 4 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.53e-04 | 179 | 67 | 4 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 180 | 67 | 4 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 180 | 67 | 4 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | ICU-NoSEP-Myeloid-tDC|ICU-NoSEP / Disease, Lineage and Cell Type | 1.56e-04 | 180 | 67 | 4 | be665e801512f6aaf6b3ecb26153bbdeb24619ac | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 180 | 67 | 4 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | droplet-Lung-nan-21m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 182 | 67 | 4 | 40539ade8c3cd12b61f1cd0d493828e58282796b | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.66e-04 | 183 | 67 | 4 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-04 | 183 | 67 | 4 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-04 | 183 | 67 | 4 | 274483009b309289e4cb84beedf6806430db6ff6 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-04 | 184 | 67 | 4 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-04 | 184 | 67 | 4 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.70e-04 | 184 | 67 | 4 | fa4915b0498f3069fd5ef497286445528f75187e | |
| ToppCell | PND01-03-samps-Epithelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.73e-04 | 185 | 67 | 4 | 2b854df79cfe2cb4d2f9c2938a066e0aa3649325 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.73e-04 | 185 | 67 | 4 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.73e-04 | 185 | 67 | 4 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.73e-04 | 185 | 67 | 4 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.73e-04 | 185 | 67 | 4 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 1.73e-04 | 185 | 67 | 4 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.73e-04 | 185 | 67 | 4 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 1.81e-04 | 187 | 67 | 4 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.84e-04 | 188 | 67 | 4 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.84e-04 | 188 | 67 | 4 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | facs-Lung-EPCAM-24m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 188 | 67 | 4 | c2ef270f691d367b1621d48f0771267cefe1630d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.88e-04 | 189 | 67 | 4 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.88e-04 | 189 | 67 | 4 | 2d32f09efa982ae458568f6b1cd06bb5078d42a3 | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.88e-04 | 189 | 67 | 4 | ee15b4fb3a1cfda80bcf210a23f04f242594015e | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-respiratory_basal_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.88e-04 | 189 | 67 | 4 | dc6f6fae84347d145bea71b49eaeeb3028e9c4ae | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.92e-04 | 190 | 67 | 4 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.92e-04 | 190 | 67 | 4 | a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.92e-04 | 190 | 67 | 4 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.92e-04 | 190 | 67 | 4 | 2434b8ad2976eab7d9147012c28454ab29670709 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.92e-04 | 190 | 67 | 4 | 57c136bf6d7feafb4a220877bed0cc8fdf314db2 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.92e-04 | 190 | 67 | 4 | f50b9814a1beac67dc042a8c27dfd085ceeda3a6 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.96e-04 | 191 | 67 | 4 | 72dbd2e0fabfca8d6f604df35277d3574739a0b3 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 1.96e-04 | 191 | 67 | 4 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | control-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.96e-04 | 191 | 67 | 4 | afebdc59a1f884ce3f2f5fe040e16b0e95e4e7c5 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.96e-04 | 191 | 67 | 4 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.96e-04 | 191 | 67 | 4 | 05731ece7867659c662f952812805f947032fe10 | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial_progenitor|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.00e-04 | 192 | 67 | 4 | fa2420d6117d4800f60ef6a24bcf8bf54593cd1f | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial_progenitor-epi-tip_late|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.00e-04 | 192 | 67 | 4 | 87b60014202633a4f6d19b09a5dd9276c2edecfb | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.00e-04 | 192 | 67 | 4 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 2.00e-04 | 192 | 67 | 4 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | 11.5-Airway-Epithelial-Bud_tip_adjacent|Airway / Age, Tissue, Lineage and Cell class | 2.00e-04 | 192 | 67 | 4 | fbb34a959b9bd9cb72a5195a07f4653a957e4ca8 | |
| ToppCell | facs-Lung-24m-Epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.00e-04 | 192 | 67 | 4 | ebfd8209a7353fbccb8ca7ade14b4f25822cebd2 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.00e-04 | 192 | 67 | 4 | 3f925a80b5e2b0577d573e88598a2984a5f6a789 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.00e-04 | 192 | 67 | 4 | c15841f35e24d6ef6ce2a9a6dc62e66efdc3d9d5 | |
| ToppCell | facs-Lung-24m-Epithelial-alveolar_epithelial-type_II_pneumocyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.04e-04 | 193 | 67 | 4 | 68adc680deb2f1a29d3cca19c13b9f6271dd4d60 | |
| Drug | mephenytoin | 5.29e-06 | 88 | 65 | 5 | CID000004060 | |
| Drug | dichloran | 5.66e-06 | 41 | 65 | 4 | CID000007430 | |
| Drug | felodipine | 8.80e-06 | 169 | 65 | 6 | CID000003333 | |
| Drug | mono-(2-ethylhexyl)phthalate | 1.62e-05 | 658 | 65 | 10 | ctd:C016599 | |
| Drug | pleuromutilin | 1.76e-05 | 18 | 65 | 3 | CID000031326 | |
| Drug | Fluphenazine dihydrochloride [146-56-5]; Up 200; 7.8uM; PC3; HT_HG-U133A | 1.93e-05 | 194 | 65 | 6 | 5880_UP | |
| Drug | Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.04e-05 | 196 | 65 | 6 | 5409_DN | |
| Drug | 8-MOP | 2.21e-05 | 118 | 65 | 5 | CID000004114 | |
| Drug | diclofenac | 2.93e-05 | 209 | 65 | 6 | CID000003032 | |
| Drug | clofibrate | 2.93e-05 | 311 | 65 | 7 | CID000002796 | |
| Drug | propoxyphene | 4.05e-05 | 67 | 65 | 4 | CID000010100 | |
| Drug | aminoglutethimide | 4.53e-05 | 137 | 65 | 5 | CID000002145 | |
| Drug | ebastine | 4.88e-05 | 25 | 65 | 3 | CID000003191 | |
| Drug | carteolol | 5.38e-05 | 72 | 65 | 4 | CID000002583 | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 1.81e-04 | 9 | 67 | 2 | EFO_0800562 | |
| Disease | coffee consumption measurement | 7.93e-04 | 182 | 67 | 4 | EFO_0006781 | |
| Disease | age at voice drop | 1.14e-03 | 22 | 67 | 2 | EFO_0007888 | |
| Disease | Subfertility, Female | 1.85e-03 | 28 | 67 | 2 | C0341869 | |
| Disease | Sterility, Postpartum | 1.85e-03 | 28 | 67 | 2 | C0038279 | |
| Disease | Female sterility | 1.85e-03 | 28 | 67 | 2 | C0917730 | |
| Disease | Female infertility | 1.85e-03 | 28 | 67 | 2 | C0021361 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ELLLLRDDGEEEFAG | 651 | Q8N163 | |
| GFELVTDLILADFLL | 256 | Q9H993 | |
| LILELVAGGELFDFL | 91 | P53355 | |
| ELDLSELEGLGLSDT | 21 | Q13015 | |
| EDLLCVLIDDGGFLV | 886 | Q9NY47 | |
| LKEFDLDALLGIDDL | 91 | P18848 | |
| LSVGLEDEEDLLEDL | 376 | P32929 | |
| LVLTLEGEDLGELDK | 586 | O94985 | |
| EEEEGDLLLFLTGQE | 346 | O43143 | |
| LGSGEELDLLSEILD | 551 | Q8IV53 | |
| SELEDDLLGEDLLSG | 41 | Q96EV2 | |
| DGLDLKDIIIDLGEI | 131 | Q7RTW8 | |
| EILLDLGFGADEPDI | 146 | Q6ZRS4 | |
| LGEELEALRGELEDT | 1161 | Q7Z406 | |
| LDSLDGLALDIVSGL | 296 | A0A0J9YX94 | |
| FDIELLELVAGLPEG | 41 | Q75LS8 | |
| LSEEELLDKLEIFFG | 146 | P80217 | |
| LLDVFLGLETDGEEL | 206 | Q8N2G8 | |
| DSEILDLESELYLGG | 616 | Q9P2S2 | |
| AALGEVEDEGLLASL | 16 | Q96MW5 | |
| LILELVSGGELFDFL | 91 | O43293 | |
| LTFSEGLDELLKLEG | 1051 | P48357 | |
| VDEELGLDLGDLSRF | 236 | Q13087 | |
| ALDDDGDLSDLGVIL | 451 | Q8TE96 | |
| TLDEGLIEFGTAIDD | 591 | Q9UG01 | |
| LDLTDAIEEGTLDGL | 1601 | Q9UG01 | |
| LGEILIELETALLDD | 846 | Q86UR5 | |
| DLQLLEDGDLTVIGD | 516 | O15439 | |
| LTESLFLDLLGEENG | 406 | P24394 | |
| EDGGLERKFSLDDLL | 341 | P07099 | |
| ILSEEDGDDLLLKAE | 1166 | Q9H799 | |
| LVTELFDTELIGEGA | 141 | Q9NVM4 | |
| LILELVSGGELFDFL | 101 | Q9UIK4 | |
| LEAELEKLSLSEGGL | 421 | Q8WUX9 | |
| LDFIDVLLLSKDEDG | 296 | Q9HBI6 | |
| LDFIDVLLLSKDEDG | 296 | Q9HCS2 | |
| NLFILLLGKEDGEEE | 116 | A2RUQ5 | |
| TIIEDGDDLGEVLAL | 131 | Q96BJ8 | |
| LDFIDVLLLSKDEDG | 296 | P78329 | |
| GFLLPDSDVEIDLEL | 726 | P32019 | |
| EEGEDVVGDILADLL | 51 | A6NN90 | |
| LDFIDVLLLSKDEDG | 296 | Q08477 | |
| AGEQELLLLLEPEEF | 136 | A4GXA9 | |
| DLLAFLLEESGDLGT | 11 | O43889 | |
| ELVTLEEADGGSDIL | 126 | Q9P1Z2 | |
| DLGEKTFEGDIQELL | 191 | P25940 | |
| TGFIDGDLIESFLDI | 1086 | Q16531 | |
| ELELDELLEAIEQGG | 1156 | P10586 | |
| RELLATLEGLDLDGE | 596 | Q53GL7 | |
| EGADKDDLLLLSEIF | 366 | Q05084 | |
| DLELESEQEAGLGLD | 861 | Q96RN1 | |
| GLGLDLDLDRELEPE | 871 | Q96RN1 | |
| EAEEFQLEVSGLLGE | 71 | Q8NCA5 | |
| ELPLELGEAILAEEF | 396 | Q9BVL4 | |
| LFEVGDAVEGLELTE | 331 | P08F94 | |
| LGRDLGSDETDLILL | 41 | Q9H6T0 | |
| LDDGLEGLFEDIDTS | 166 | Q9UHV2 | |
| IDFIDEGRLLLEFDL | 141 | O75908 | |
| GDELQDELFELLGPE | 261 | Q8N3C0 | |
| DELFELLGPEGLELI | 266 | Q8N3C0 | |
| FEELILLLEAALGLE | 1296 | P53675 | |
| LEELGLDLESGEESN | 136 | O95625 | |
| GFEGLLLVDDDLLGV | 101 | Q5XPI4 | |
| DLDLFLDLGDLEEPQ | 216 | Q9H6E5 | |
| LTELGDELTLGDIDE | 16 | Q12772 | |
| SLCKLEGGEELEEEL | 206 | Q9UFB7 | |
| TFELSADEVELGLGI | 206 | Q3LXA3 | |
| GLLGDATEEFIESLD | 4446 | Q5T4S7 | |
| LLELLLEEDDGTGLC | 171 | Q68DK2 | |
| GEDDTILDLTGDALD | 1196 | Q5VTT5 |